| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.4B | $3.3B | $2.6B | $1.9B | $1.6B | $1.4B | $0.3B | $0.3B |
| Cost of Revenue | $0.9B | $0.8B | $0.6B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.4B | $1.3B | $1.2B | $1.1B | $1.0B | $0.7B | $0.2B | $0.2B |
| Net Income | $1.0B | $0.9B | $0.8B | $0.9B | $0.8B | $0.5B | $0.1B | $0.1B |
| EPS (Basic) | $4.59 | $4.03 | $4.74 | $6.41 | $6.20 | $3.71 | $0.87 | $0.80 |
| EPS (Diluted) | $4.59 | $4.03 | $4.74 | $6.41 | $6.19 | $3.71 | $0.86 | $0.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.3B | $28.8B | $27.5B | $12.2B | $10.5B | $9.4B | $8.5B | $7.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $14.9B | $14.0B | $12.0B | $8.1B | $6.7B | $6.5B | $5.6B | $5.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $13.4B | $13.9B | $14.4B | $3.3B | $3.1B | $2.5B | $2.5B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $1.9B | $1.4B | $1.2B | $1.0B | $0.8B | $0.7B | $0.7B |
| Investing Cash Flow | $-0.8B | $-1.6B | $-1.8B | $-1.6B | $-0.8B | $-1.0B | $-0.6B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.0B | $-0.2B | $0.4B | $0.4B | $-0.2B | $0.2B | $-0.1B | $-0.2B |